BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27071941)

  • 1. Arsenite and Cadmium Activate MAPK/ERK via Membrane Estrogen Receptors and G-Protein Coupled Estrogen Receptor Signaling in Human Lung Adenocarcinoma Cells.
    Huff MO; Todd SL; Smith AL; Elpers JT; Smith AP; Murphy RD; Bleser-Shartzer AS; Hoerter JE; Radde BN; Klinge CM
    Toxicol Sci; 2016 Jul; 152(1):62-71. PubMed ID: 27071941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium arsenite inhibited genomic estrogen signaling but induced pERα (Ser118) via MAPK pathway in breast cancer cells.
    Nakareangrit W; Thiantanawat A; Visitnonthachai D; Watcharasit P; Satayavivad J
    Environ Toxicol; 2016 Sep; 31(9):1133-46. PubMed ID: 25728338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of aromatase activation on sodium arsenite-induced proliferation, migration, and invasion of MDA-MB-231 and MDA-MB-453 breast cancer cell lines.
    Reyes-Vázquez L; Hernández AJA; Calderón-Aranda ES
    Toxicology; 2020 May; 437():152440. PubMed ID: 32197950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced activation of MAPK/ERK pathway in human breast cancer MCF-7 cells.
    Song X; Wei Z; Shaikh ZA
    Toxicol Appl Pharmacol; 2015 Aug; 287(1):26-34. PubMed ID: 26006730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of activating ERK1/2 through G protein coupled receptor 30 and estrogen receptor α/β in low doses of bisphenol A promoting growth of Sertoli TM4 cells.
    Ge LC; Chen ZJ; Liu HY; Zhang KS; Liu H; Huang HB; Zhang G; Wong CK; Giesy JP; Du J; Wang HS
    Toxicol Lett; 2014 Apr; 226(1):81-9. PubMed ID: 24495410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
    Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib.
    Girgert R; Emons G; Gründker C
    Oncol Rep; 2017 Feb; 37(2):1212-1218. PubMed ID: 27959426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cadmium at nanomolar concentrations activates Raf-MEK-ERK1/2 MAPKs signaling via EGFR in human cancer cell lines.
    Ali I; Damdimopoulou P; Stenius U; Halldin K
    Chem Biol Interact; 2015 Apr; 231():44-52. PubMed ID: 25744307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of pertussis toxin on GPER-mediated activation of phosphatidylinositol 3-kinase/protein kinase B signaling induced by 17β-estradiol in endometrial carcinoma cells].
    Guo RX; Lei J; Wang XY; Ge X; Hu DM; Ma XY; Li LX; Qiao YH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):129-33. PubMed ID: 23544495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ; Quinn JA; Bland KI; Frackelton AR
    Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The membrane estrogen receptor GPR30 mediates cadmium-induced proliferation of breast cancer cells.
    Yu X; Filardo EJ; Shaikh ZA
    Toxicol Appl Pharmacol; 2010 May; 245(1):83-90. PubMed ID: 20153348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.
    Vivacqua A; Romeo E; De Marco P; De Francesco EM; Abonante S; Maggiolini M
    Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells.
    Lappano R; Rosano C; Santolla MF; Pupo M; De Francesco EM; De Marco P; Ponassi M; Spallarossa A; Ranise A; Maggiolini M
    Curr Cancer Drug Targets; 2012 Jun; 12(5):531-42. PubMed ID: 22414008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer.
    Liu C; Liao Y; Fan S; Fu X; Xiong J; Zhou S; Zou M; Wang J
    Oncol Res; 2019 Feb; 27(3):283-292. PubMed ID: 28877783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cadmium on estrogen receptor mediated signaling and estrogen induced DNA synthesis in T47D human breast cancer cells.
    Zang Y; Odwin-Dacosta S; Yager JD
    Toxicol Lett; 2009 Jan; 184(2):134-8. PubMed ID: 19041697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells.
    Lappano R; Mallet C; Rizzuti B; Grande F; Galli GR; Byrne C; Broutin I; Boudieu L; Eschalier A; Jacquot Y; Maggiolini M
    Cells; 2019 Jun; 8(6):. PubMed ID: 31207943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPER/ERK&AKT/NF-κB pathway is involved in cadmium-induced proliferation, invasion and migration of GPER-positive thyroid cancer cells.
    Zhu P; Liao LY; Zhao TT; Mo XM; Chen GG; Liu ZM
    Mol Cell Endocrinol; 2017 Feb; 442():68-80. PubMed ID: 27940299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphenol A and Related Alkylphenols Exert Nongenomic Estrogenic Actions Through a G Protein-Coupled Estrogen Receptor 1 (Gper)/Epidermal Growth Factor Receptor (Egfr) Pathway to Inhibit Meiotic Maturation of Zebrafish Oocytes.
    Fitzgerald AC; Peyton C; Dong J; Thomas P
    Biol Reprod; 2015 Dec; 93(6):135. PubMed ID: 26490843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidences for involvement of estrogen receptor induced ERK1/2 activation in ovarian cancer cell proliferation by Cadmium Chloride.
    Ataei N; Aghaei M; Panjehpour M
    Toxicol In Vitro; 2019 Apr; 56():184-193. PubMed ID: 30682495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
    Filardo EJ; Quinn JA; Frackelton AR; Bland KI
    Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.